Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Tests prevented relapse and limited graft-vs.-host disease (GVHD) in laboratory models of leukemia and multiple myeloma.
Tumor immune microenvironments may provide clues to future therapies, say UCSF-led researchers.
Our bodies can keep tumors at bay, even if our cells harbor cancer-driving mutations.
Researchers found that shutting down the effects of the abnormal collagen made treatments for pancreatic cancer more effective.
Many cancer patients eligible for CAR-T therapy must live away from home for several months while they complete treatment.
Most pancreatic cancer cells have relatively few mutations on their surface to attract the attention of cancer-killing immune T cells.
Around 20% to 30% of meningiomas are aggressive and potentially deadly.
Vaccines designed to produce a strong T cell response may help protect against current and future SARS-CoV-2 variants.
Extra vaccine doses, monoclonal antibodies and antivirals can help prevent severe illness.
Allergy meds were linked to longer survival among cancer patients treated with immune checkpoint inhibitors.
Discovery in head and neck cancers may open door for targeted immune-boosting drugs
“While this approach is not restricted to analyzing tumor tissues, there are obvious applications for better understanding cancer."
Researchers hope to easily identify which colon cancer patients are unlikely to benefit from immune checkpoint inhibitors (ICIs).
New insights into why men fail to mount as powerful an immune response to many cancers as women do.
Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.
Removing naive T cells before a stem cell transplant in certain cancer patients may prevent chronic graft-versus-host disease.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.